SNT Stock Overview
Provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for SNT from our risk checks.
Synektik Spólka Akcyjna Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł145.20 |
| 52 Week High | zł157.00 |
| 52 Week Low | zł54.60 |
| Beta | 1.24 |
| 11 Month Change | -2.02% |
| 3 Month Change | -0.95% |
| 1 Year Change | 118.02% |
| 33 Year Change | 363.90% |
| 5 Year Change | 891.80% |
| Change since IPO | 1,664.28% |
Recent News & Updates
Synektik Spólka Akcyjna's (WSE:SNT) Performance Is Even Better Than Its Earnings Suggest
Aug 13
Broker Revenue Forecasts For Synektik Spólka Akcyjna (WSE:SNT) Are Surging Higher
Jun 29Recent updates
Synektik Spólka Akcyjna's (WSE:SNT) Performance Is Even Better Than Its Earnings Suggest
Aug 13Broker Revenue Forecasts For Synektik Spólka Akcyjna (WSE:SNT) Are Surging Higher
Jun 29Why The 44% Return On Capital At Synektik Spólka Akcyjna (WSE:SNT) Should Have Your Attention
Mar 13Synektik Spólka Akcyjna (WSE:SNT) Looks Just Right With A 26% Price Jump
Feb 15Here's Why We Think Synektik Spólka Akcyjna (WSE:SNT) Might Deserve Your Attention Today
Feb 08Solid Earnings Reflect Synektik Spólka Akcyjna's (WSE:SNT) Strength As A Business
Jan 26Estimating The Intrinsic Value Of Synektik Spólka Akcyjna (WSE:SNT)
Dec 15Synektik Spólka Akcyjna (WSE:SNT) Has A Rock Solid Balance Sheet
Sep 12We Like Synektik Spólka Akcyjna's (WSE:SNT) Returns And Here's How They're Trending
Jun 22Is Now The Time To Put Synektik Spólka Akcyjna (WSE:SNT) On Your Watchlist?
May 23Is Synektik Spólka Akcyjna (WSE:SNT) A Risky Investment?
Oct 04Is Synektik Spólka Akcyjna (WSE:SNT) A Risky Investment?
Oct 27Synektik Spólka Akcyjna (WSE:SNT) Is Posting Promising Earnings But The Good News Doesn’t Stop There
Jun 22These 4 Measures Indicate That Synektik Spólka Akcyjna (WSE:SNT) Is Using Debt Safely
Jun 10Does Synektik Spólka Akcyjna (WSE:SNT) Have A Healthy Balance Sheet?
Mar 09Synektik Spólka Akcyjna (WSE:SNT) Looks Like A Good Stock, And It's Going Ex-Dividend Soon
Feb 13Does Synektik Spólka Akcyjna (WSE:SNT) Have A Place In Your Dividend Portfolio?
Jan 25
Is Synektik Spólka Akcyjna's (WSE:SNT) Latest Stock Performance A Reflection Of Its Financial Health?
Dec 25Is Synektik Spólka Akcyjna (WSE:SNT) A Risky Investment?
Nov 30Shareholder Returns
| SNT | PL Healthcare Services | PL Market | |
|---|---|---|---|
| 7D | 5.2% | -0.3% | -0.7% |
| 1Y | 118.0% | -1.9% | 16.7% |
Return vs Industry: SNT exceeded the Polish Healthcare Services industry which returned -1.9% over the past year.
Return vs Market: SNT exceeded the Polish Market which returned 16.7% over the past year.
Price Volatility
| SNT volatility | |
|---|---|
| SNT Average Weekly Movement | 5.5% |
| Healthcare Services Industry Average Movement | 5.5% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in PL Market | 9.3% |
| 10% least volatile stocks in PL Market | 3.4% |
Stable Share Price: SNT has not had significant price volatility in the past 3 months.
Volatility Over Time: SNT's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 164 | Cezary Kozanecki | www.synektik.com.pl |
Synektik Spólka Akcyjna provides products, services, and IT solutions for surgery, diagnostic imaging, and nuclear medicine applications in Poland. The company sells medical equipment used in diagnostics and therapy, and nuclear medicine. It is also involved in development of IT solutions used in radiology, as well as researches, produces, and sells radiopharmaceutical products used in diagnostics for oncology.
Synektik Spólka Akcyjna Fundamentals Summary
| SNT fundamental statistics | |
|---|---|
| Market cap | zł1.24b |
| Earnings (TTM) | zł79.47m |
| Revenue (TTM) | zł618.67m |
15.6x
P/E Ratio2.0x
P/S RatioIs SNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SNT income statement (TTM) | |
|---|---|
| Revenue | zł618.67m |
| Cost of Revenue | zł432.24m |
| Gross Profit | zł186.43m |
| Other Expenses | zł106.95m |
| Earnings | zł79.47m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 9.32 |
| Gross Margin | 30.13% |
| Net Profit Margin | 12.85% |
| Debt/Equity Ratio | 0% |
How did SNT perform over the long term?
See historical performance and comparison